{"id":"W3133746780","doi":"10.1016/s0140-6736(21)00213-0","title":"Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1302,"is_retracted":false,"has_abstract":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Placebo; Overweight; Type 2 diabetes; Internal medicine; Body mass index; Diabetes mellitus; Randomized controlled trial; Glycated hemoglobin; Physical therapy; Endocrinology; Liraglutide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194699,0.002131783,0.003955975,0.0004986575,0.0003880987,0.001159483,0.0009193154,0.002480636,0.009210828],"category_scores_gemma":[0.001158977,0.0007636288,0.00266268,0.0004647871,0.0007761247,0.001121572,0.0005011705,0.003197142,0.001645977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004637893,"about_ca_system_score_gemma":0.0008297042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001657002,"about_ca_topic_score_gemma":0.003712962,"domain_scores_codex":[0.9996703,0.000134489,0.00002232949,0.00007516616,0.00002885974,0.0000689966],"domain_scores_gemma":[0.9995993,0.000116744,0.00007711275,0.00002853207,0.00002857943,0.0001497854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830747,0.002297478,0.0003377146,0.001302337,0.001304775,0.00005268476,0.00003768508,0.000158787,0.001575393,0.00008040326,0.001181647,0.008596427],"study_design_scores_gemma":[0.9837742,0.01405041,0.001053058,0.00004332767,0.0004087948,0.00002087642,0.000014681,0.0001361008,0.0000951871,0.00006890253,0.0003242159,0.00001016344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678797,0.01515538,0.001107638,0.001587366,0.001711412,0.005022104,0.002566103,0.0004868668,0.004483495],"genre_scores_gemma":[0.9619941,0.01111582,0.002860669,0.004328948,0.0009188182,0.006754152,0.002380955,0.00007870638,0.009567843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009210828,"threshold_uncertainty_score":0.03081328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03487184394042082,"score_gpt":0.2963627505833139,"score_spread":0.2614909066428931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}